Choosing the Right Tests for Surgical and Ophthalmic Instruments

First, the scope: which instruments this article covers

This article is about surgical instruments and ophthalmic surgical instruments - forceps, scissors, knives, needle holders and retractors, together with the microforceps, capsulotomy scissors, irrigation/aspiration tips and cannulae used in eye surgery. In short, hand-held and hand-operated instruments, in both single-use and reprocessable forms.

Three product families sit outside that scope. If your product is one of them, building a test request from the list below will leave out the tests that actually decide the outcome:

• Intraocular lenses, contact lenses, ophthalmic viscosurgical devices, intraocular tamponades and other products implanted in or in prolonged contact with ocular tissue. Each has its own dedicated standards framework, setting performance endpoints and evaluation routes this article does not touch; a generic biological evaluation plus packaging list falls well short of covering them. Which framework applies, and which edition governs, is determined by the currently effective version of the applicable product-specific standard. If you are not sure where your product sits, confirm it with us first before fixing the test list, rather than shipping samples against a generic list and sorting it out afterwards.
• Dental hand and rotary instruments. They belong to the same broad family, but connection dimensions and fit, cutting efficiency and durability, and performance retention after repeated sterilisation are dimensions of their own. A separate article deals with them; they are not repeated here.
• Active surgical instruments with energy output. For electrosurgical handpieces, powered tools and similar products, electrical safety and electromagnetic compatibility form an independent route that runs in parallel with the material, cleaning and packaging route discussed here. Neither substitutes for the other. The surgical instrument testing service page shows how the work divides.

With the scope settled, here is how the list gets built.

Answer three questions and half the test list writes itself

When a team is asked "what testing does this product need", the reflex is to find a comparable product's test list and copy it. Surgical and ophthalmic instruments are two of the categories where that reflex fails most often. Two devices can both be called surgical scissors, yet the verification route for a reprocessable pair barely overlaps with that of a single-use pair. Two ophthalmic cannulae can look nearly identical, yet one touches only the ocular surface while the other enters the eye, and the granularity of the biological evaluation differs accordingly.

Before drafting anything, write one sentence for each of the following.

Is the instrument single-use or reprocessable? This decides whether reprocessing information has to be developed and validated along the lines of the ISO 17664 series. It also decides whether material evaluation is done on the single-use condition, or whether performance and extractables after repeated cleaning, disinfection and sterilisation have to be considered as well.

Is it supplied sterile? If it is, the packaging system becomes a separate work package under the ISO 11607 framework, and sterilisation process validation is scheduled separately. If it is not, the description of pre-use processing in the instructions becomes part of product safety in its own right - which means it has to be written with more care, not less.

What part of the body does it contact, in what manner, and for how long in total? This is the entry point into the ISO 10993 series and the GB/T 16886 series, with the classification principles set out in ISO 10993-1. Most surgical instruments land in the surface or externally communicating categories with limited contact duration; ophthalmic surgical instruments frequently contact intraocular tissue. The two cannot share the same granularity.

If these three questions have no clear answers, the resulting list will inevitably be padded just in case: you spend the money, and you can still be asked to add work during review because a key piece of reasoning is missing.

Surgical instruments: the material looks simple, the trouble is in the surface and the structure

Stainless steel instruments are often assumed to be "a mature material with nothing much to test". In practice the problems rarely come from the base metal. They come from surface condition and from how accessible the structure is.

Surface condition. After grinding, polishing, passivation, electrochemical marking and laser marking, the surface composition is no longer that of the base metal. Marked areas, weld heat-affected zones and batch-to-batch variation in passivation all affect corrosion behaviour, and therefore integrity after repeated processing. The verification here runs in the direction of corrosion resistance and visual integrity; the test conditions and acceptance limits are governed by the currently effective version of the standard text.

Structural accessibility. Hinges, serrations, blind holes, long narrow lumens and joint faces that may or may not be dismantled are where cleaning validation actually gets difficult. What follows is engineering analysis rather than a statistical conclusion: contamination in blind ends and narrow gaps is carried away by diffusion and convection, so the narrower the channel and the larger the dead volume, the higher the mass-transfer resistance. A cleaning procedure that works on a solid-shaft instrument will not necessarily work on a lumened one. "One instruction for use covers the whole range" is therefore a high-risk approach. Group the range into families by structural complexity, and pick a hard-to-clean representative within each family.

Instruments with polymer parts or coatings. Overmoulded handles, insulation, seals and non-stick coatings are the main sources of biological evaluation and chemical characterisation work. Conclusions drawn on the metal parts do not automatically extend to them. One overmoulded component missing from the bill of materials usually means another round of testing later on.

Functional performance is defined by the product's own technical requirements. Cutting, gripping, jaw closure and ratchet retention are not covered by generic standard lists. The manufacturer has to state the specification and the pass/fail approach in the technical requirements first; the laboratory then matches a method to it. This is routinely left until last, and it is exactly the part reviewers tend to probe.

Ophthalmic surgical instruments: the contact site sets the level of scrutiny

What makes ophthalmic instruments special is not that they are small. It is that ocular tissue is sensitive to irritation and residues, and that the anterior chamber is a closed space with almost no immunological buffering.

Ocular-surface contact and intraocular contact must be characterised separately. An instrument that only touches the conjunctiva and the corneal surface sits differently in the ISO 10993-1 contact classification from one that passes through an incision into the anterior chamber or the vitreous cavity, and the set of evaluation endpoints differs with it. A common deviation in submissions is to scope an intraocular instrument as if it were an ocular-surface one, and to discover the gap only during review - at which point samples, lead time and budget all have to be rearranged.

Residues are the underestimated risk in ophthalmology. The toxic anterior segment reactions discussed clinically are generally attributed to a combination of factors: detergent residues, sterilant residues, endotoxin and metal ions. The practical consequence is twofold. For reprocessable ophthalmic instruments, cleaning validation has to show not only that soil was removed but that the detergent itself was rinsed away. For single-use ophthalmic instruments, residues arising from the sterilisation method have to be part of the evaluation. Neither is something a material certificate can settle.

Cytotoxicity and irritation endpoints need their own justification in an ophthalmic context. Cytotoxicity-related endpoints are normally run to ISO 10993-5, and irritation and sensitisation endpoints to ISO 10993-10, but which model is used, and in what condition and under what extraction conditions the samples are tested, has to be explained in the evaluation plan with reference to the actual intraocular situation. You cannot simply lift the approach used for a skin-contacting device. Method selection and acceptance are governed by the currently effective version of the standard text and by the conclusions of the evaluation route.

Geometry and working-end performance are not on any generic list. Jaw alignment on microforceps, blade mating on capsulotomy scissors, patency and working-end dimensions on irrigation/aspiration tips - all of these depend heavily on the product's own technical requirements. Generic biological evaluation and packaging lists do not cover them. Write the performance specification first, then have the laboratory match methods to it.

Biological evaluation is an evaluation, not a pile of tests

The ISO 10993 series and the GB/T 16886 series correspond to one another. The common misunderstanding is to read them as a fixed test package. What they actually require is a process: characterise the materials, judge whether existing data can be relied on, and only then decide which endpoints need new testing. The overall classification and evaluation route is set by ISO 10993-1, with individual endpoints set by the corresponding parts of the series; which part applies and which edition governs is determined by the currently effective version of the standard text and by the evaluation route.

On that logic, biological evaluation starts from a bill of materials, not from a test request form. What the manufacturer has to supply, for each body-contacting component, is: material grade, supplier, formulation-level information (including masterbatch, plasticisers and mould release agents), processing aids, and the sterilisation method. Where that information is incomplete, the laboratory can only scope conservatively, and both cost and lead time inflate.

Three traps come up repeatedly:

• Using an old type-test report in place of an evaluation. A report containing a few biological test results is not a completed evaluation. Without characterisation and reasoning, the data cannot show that the endpoints which should have been addressed were addressed.
• Changing supplier without repeating anything. The same nominal grade from a different supplier can carry an entirely different additive package. Material changes, process changes and sterilisation changes all require a fresh judgement about whether existing data still apply.
• Sending samples in the wrong condition. Samples for biological evaluation and chemical characterisation should in principle be finished product that has been through the same sterilisation as the final device. Data generated on unsterilised semi-finished parts usually has to be repeated.

Chemical performance: when the GB/T 14233 methods come into play

Devices with polymer components, and particularly those forming a fluid path (irrigation, aspiration, drainage), normally need chemical performance data in addition to biological evaluation. The chemical analysis methods within the GB/T 14233 series provide a body of methodology used across the industry, covering directions such as reducing substances, metal ions, acidity and alkalinity, evaporation residue and ultraviolet absorbance.

Two points deserve attention. First, the method can be cited, but the extraction conditions must reflect actual clinical use: contact medium, contact time and the surface-area-to-volume relationship all need a rationale, and none of it should be copied from another product. Second, this chemical performance data is not the same thing as chemical characterisation under the ISO 10993 series. The former is prescribed-method data supporting release and registration; the latter identifies constituents in support of a toxicological risk assessment. They can support each other, but they do not substitute for each other. Method selection and limits are governed by the currently effective version of the standard text.

Supplied sterile: where packaging ends and reprocessing begins

Packaging. For terminally sterilised medical devices, the ISO 11607 framework requires three things to be established: the performance of materials and preformed systems, validation of the forming and sealing processes, and retention of package integrity over shelf life and after distribution. Surgical and ophthalmic instruments share one risk here - tips and cutting edges. In engineering terms, sharp geometry creates local stress concentration in flexible packaging, and when transport vibration combines with stacking load, puncture failure often precedes seal failure. Protective caps, liners and thermoformed trays therefore have to be designed together with the packaging validation plan. Adding protective components after the packaging is finalised means repeating validation you have already paid for.

Reprocessing. This section only sorts the decision; it does not go into method. Three steps: single-use or reprocessable; supplied sterile or not; supplied with reprocessing instructions or not. Only when all three point to reprocessable do you need to develop and validate the processing method under the ISO 17664 framework, and state the limitation on reprocessing or the criterion for withdrawal from use. Which part of the series applies depends on device type and processing method, and is governed by the currently effective version of the standard text. Validation approach, the information elements the instructions have to cover, and the common reasons for rejection are dealt with in a separate article. One reminder only: copying a competitor's instructions for use is a high-risk shortcut, because their method was validated for their structure and their materials - and once your instructions are published, the burden of proof sits with you.

One table: common situations and the verification directions they imply

The table lists decision directions, not a complete test list. The actual items and acceptance limits are governed by the currently effective version of the standard text and by the product's own technical requirements.

Prepare these before you ship samples and you save a round of rework

When assembling documents against the sample submission requirements, surgical and ophthalmic instruments in particular need the following:

• A complete bill of materials, stating for each component whether it contacts the body, the contact site and mode, the material grade and supplier, and masterbatch and additive information.
• The sterilisation method and its validation status. Samples should be in the same post-sterilisation condition as the finished product, and the method should be stated. If ethylene oxide is used, set aside samples for residue work as well.
• Draft instructions for use and labelling, especially the processing section for reprocessable instruments. This draft is usually what the laboratory uses to decide which steps need validating.
• Structural drawings and disassembly instructions, used to determine sampling points for cleaning validation, the hard-to-clean features and the family grouping.
• The functional specifications from the product technical requirements, including working-end dimensions and the specification and pass/fail approach for fit and retention. Generic standards do not cover this, and without it the laboratory cannot propose a method for the functional items.
• Change history. If the product has changed raw material supplier, formulation or sterilisation method, say so up front, so it can be judged whether existing data can still be cited.

On sample quantity, prepare units from a single batch that cover the boundary cases across the size range, and hold back units for retest. Sampling for instruments is often constrained by cost; boundary configurations - long narrow lumens, complex hinges, longer working lengths - are more representative than mid-range ones. That is an engineering judgement, not a statistical conclusion.

About SUNGO Lab

SUNGO Lab (Shanghai Shage Medical Technology Co., Ltd.) operates laboratories in Shanghai and Hefei and is accredited by CNAS, CMA and IAS (USA), covering surgical drapes and gowns, masks, wheelchairs, EMC, electrical safety, biocompatibility, sterilisation, packaging, transport and shelf-life testing. To be clear, an accreditation mark only demonstrates that the laboratory holds the corresponding technical competence within its accredited scope; it does not constitute a commitment as to market access outcomes, which are decided by the relevant regulatory authority.

For surgical and ophthalmic surgical instruments we can help work through contact classification and the evaluation route, run biocompatibility and chemical performance testing, support packaging system validation and the design approach for reprocessing, and check sample condition and document completeness before submission so that rework is reduced. Scheduling and cost depend directly on product structure, material types and the number of configurations, so it is worth a conversation before the plan is fixed. More background is available in our technical knowledge base.

Call +86 132 4819 8029 or request a quote, and we will come back with a test plan and lead-time estimate matched to your product structure and target market.